IP Verse

Laboratorios Liconsa, S.a. opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Dosage Regimen For A S1P Receptor Agonist

Applicant:

Opposition Date:

Mar 3, 2021

Patent Number:

Title:

Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release Tablets

Applicant:

Opposition Date:

Dec 23, 2020

Patent Number:

Title:

Pharmaceutical Compositions Comprising An S1P Modulator

Applicant:

Opposition Date:

Apr 3, 2020

Patent Number	Title	Applicant	Opposition Date
EP3453387	Dosage Regimen For A S1P Receptor Agonist	NOVARTIS AG	Mar 3, 2021
EP3102187	Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release Tablets	GALENICUM HEALTH S.L.	Dec 23, 2020
EP3103448	Pharmaceutical Compositions Comprising An S1P Modulator	NOVARTIS AG	Apr 3, 2020

NOVARTIS AG

GALENICUM HEALTH S.L.

GALENICUM HEALTH S.L.U.

Feel free to send us a message here and we will get back to you